rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

James Yang Liu

VP ACCT, Cntlr, Treasurer, PAO

Company insider

Files Form 4 as: VP ACCT, Cntlr, Treasurer, PAO, Insight Molecular Diagnostics.

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
17 Jan 2023
Last trade
26 Mar 2026
Last filed
30 Mar 2026

Companies traded

Where they are an officer
IMDX Insight Molecular DiagnosticsOfficer · Diagnostics & Labs · last 26 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
26 Mar 2026filed 30 Mar 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Code M—6,289filing
26 Mar 2026filed 30 Mar 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Code F$11K2,578 at $4.11filing
26 Mar 2026filed 30 Mar 2026IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—6,289 at $0.00filing
26 Mar 2026filed 30 Mar 2026IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—6,289 at $0.00filing
26 Mar 2026filed 30 Mar 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Code M—6,289filing
26 Mar 2026filed 30 Mar 2026IMDX Insight Molecular DiagnosticsDiagnostics & LabsSEC FORM 4 Code F$11K2,578 at $4.11filing
28 Sep 2025filed 30 Sep 2025IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—18,000 at $0.00filing
26 Mar 2025filed 28 Mar 2025IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—10,000 at $0.00filing
26 Mar 2025filed 28 Mar 2025IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—18,867 at $0.00filing
20 May 2024filed 22 May 2024IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—10,000 at $0.00filing
10 Oct 2023filed 12 Oct 2023IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—8,482 at $0.00filing
17 Jan 2023filed 19 Jan 2023IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—57,065 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Lou SilvermanDirector · Director at Insight Molecular Diagnostics, filing Form 4 there in the last year
Andrew ArnoDirector · Director at Insight Molecular Diagnostics, filing Form 4 there in the last year
Andrew J. LastDirector · Director at Insight Molecular Diagnostics, filing Form 4 there in the last year
BROADWOOD PARTNERS, L.P.10% owner · 10% owner at Insight Molecular Diagnostics, filing Form 4 there in the last year
Josh RiggsCEO and President · CEO and President at Insight Molecular Diagnostics, filing Form 4 there in the last year